Analysts Predict Upside for Key S&P 100 ETF Holdings

Analysts foresee a 14.43% increase for Invesco S&P 100 Equal Weight ETF. Key underlying stocks AbbVie, Microsoft, and Johnson & Johnson show notable upside potential.

Date: 17-01-2025

AI Rating: 7

Implied Analyst Target Price and Upside Potential
The report indicates that the Invesco S&P 100 Equal Weight ETF (EQWL) has an implied analyst target price of $118.11 based on its holdings, while it's currently trading around $103.21. This suggests a potential upside of 14.43% for the ETF itself. This analysis can lead investors to view the ETF as a somewhat attractive investment given the expected price increase.

Performance of Underlying Holdings
The underlying stocks within the ETF also exhibit promising upside potential. In particular, AbbVie Inc (ABBV), Microsoft Corporation (MSFT), and Johnson & Johnson (JNJ) are highlighted with significant growth prospects. Current prices versus analyst target prices for these stocks are as follows: ABBV has an upside of 19.92% (recent price $171.35 vs. target $205.48), MSFT shows a 19.69% increase potential (recent price $426.31 vs. target $510.26), and JNJ has a projected upside of 19.52% (recent price $144.97 vs. target $173.27).

While the optimistic price targets suggest positive sentiment among analysts, there are underlying concerns that need addressing. Questions raised include whether analysts have justified these targets in light of recent developments in the companies and the industry, or if they risk being faced with potential target downgrades if projections fail to materialize.

Stocks: EQWL ABBV MSFT JNJ